Accueil>>Signaling Pathways>> Neuroscience>> 5-HT Receptor>>Alprenolol ((RS)-Alprenolol)

Alprenolol ((RS)-Alprenolol) (Synonyms: (±)-Alprenolol, dl-Alprenolol, (RS)-Alprenolol)

Catalog No.GC32905

Alprénolol ((RS)-Alprenolol) ((RS)-Alprenolol ((RS)-Alprenolol); dl-Alprenolol ((RS)-Alprenolol)) est un ⋲-antagoniste des récepteurs adrénergiques non sélectif actif par voie orale et un antagoniste de 5 -Récepteurs HT1A et 5-HT1B. L'alprénolol ((RS)-Alprenolol) est utilisé comme agent anti-hypertenseur, anti-angineux et anti-arythmique.

Products are for research use only. Not for human use. We do not sell to patients.

Alprenolol ((RS)-Alprenolol) Chemical Structure

Cas No.: 13655-52-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
67,00 $US
En stock
50mg
61,00 $US
En stock
100mg
101,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Alprenolol is a non-selective beta blocker as well as 5-HT1A receptor antagonist.The reference for administration is 10 mg/kg.

[1]. Schreiber R et al. Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):211-5. [2]. Millan MJ et al. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther, 1994 Jan, 2

Avis

Review for Alprenolol ((RS)-Alprenolol)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Alprenolol ((RS)-Alprenolol)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.